Virus Diseases
📧 Sign up to get email alerts when something new happens for Virus Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults [Phase 1]
Phase 1 trial assessing safety and immune response of varying doses of a COVID-19 vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine [Phase 4]
A Phase 4 clinical trial evaluated antibody persistence up to 15 years after a single booster dose of Encepur Adults (GSK) vaccine.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly [Phase 3]
Phase 3 trial evaluating a plant-derived quadrivalent virus-like particle (VLP) vaccine in elderly populations has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety [Phase 3]
Phase III clinical study assessing SYN023 for rabies has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 [Phase 2]
Phase 2 trial update on prophylactic use of azithromycin with hydroxychloroquine in hospitalized COVID-19 patients; study terminated with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Bacillus Calmette-guérin Vaccination to Prevent COVID-19 [Phase 4]
Phase 4 trial update on Bacillus Calmette-Guérin vaccination to prevent COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults [Phase 2]
Phase 2 trial update on immunogenicity, safety and tolerability of a plant-derived quadrivalent influenza vaccine in adults.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults [Phase 2]
Phase 2 clinical trial assessing immunogenicity, safety, and tolerability of a plant-derived quadrivalent VLP influenza vaccine in elderly a…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) [Phase 3]
Phase 3 trial assessing safety, tolerability, and immunogenicity of V419 in healthy infants at 2, 3, 4, and 12 months; study completed with …
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V419 in healthy infants at 2, 4, and 11–12 months; completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) [Phase 3]
Phase 3 clinical trial update for a mixed HEXA/PENTA/HEXA schedule (V419-010) completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) [Phase 3]
Phase 3 clinical trial update for V419 given with Prevnar 13 and RotaTeq; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) [Phase 3]
Phase 3 clinical trial update on V419 given with Prevnar 13 and RotaTeq, focusing on safety, tolerability, and immunogenicity; study complet…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Clinical trial update on intravenous vitamin C for viral infections, including herpes zoster (shingles); completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
This is a completed National Cancer Institute clinical trial update covering studies in muscular dystrophy, retinal degeneration, skin disea…